Cancer Family
Malignant Nervous System Neoplasm
CI-CAN-00000246Explore in graph →
953 active trials7 approved drugs131 evidence items
- NCIt
- C4788
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000246Explore in graph →
Clinical trials
3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (495)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00730444 | Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma | approved for marketing | — | — | GE HealthcareINDUSTRY | 1 | Nov 9, 2009 | clinicaltrials |
| NCT00165139 | Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas | completed | Phase 2 | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00486564 | Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma | completed | Phase 1 | 20 | University of VermontOTHER | 1 | Oct 23, 2009 | clinicaltrials |
| NCT00006246 | Busulfan in Treating Children and Adolescents With Refractory CNS Cancer | completed | Phase 1 | 28 | Pediatric Brain Tumor ConsortiumNETWORK | 1 | Oct 7, 2009 | clinicaltrials |
| NCT00376103 | Radiation Boost for Newly Diagnosed Glioblastoma Multiforme | terminated | Phase 1 / Phase 2 | 3 | Methodist Healthcare - MemphisOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00548938 | Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM | terminated | Phase 2 | 40 | Methodist Healthcare - MemphisOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00590096 | I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma | completed | — | 1,380 | Children's Hospital Medical Center, CincinnatiOTHER | 0 | Aug 25, 2009 | clinicaltrials |
| NCT00418327 | Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma | completed | Phase 1 | 48 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Aug 7, 2009 | clinicaltrials |
| NCT00944801 | Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma | completed | Phase 1 / Phase 2 | 63 | University of RegensburgOTHER | 1 | Jul 23, 2009 | clinicaltrials |
| NCT00591058 | Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma | unknown | Phase 1 | 36 | TransMolecularINDUSTRY | 1 | Jul 17, 2009 | clinicaltrials |
| NCT00683761 | A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma | unknown | Phase 1 / Phase 2 | 64 | TransMolecularINDUSTRY | 1 | Jul 17, 2009 | clinicaltrials |
| NCT00599703 | Language Function in Patients With Brain Tumors | completed | — | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00032903 | This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma. | completed | Phase 1 / Phase 2 | 59 | Sigma-Tau Research, Inc.INDUSTRY | 1 | Jun 3, 2009 | clinicaltrials |
| NCT00186849 | Therapy for Children With Advanced Stage High Risk Neuroblastoma | completed | Phase 2 | 30 | St. Jude Children's Research HospitalOTHER | 1 | May 20, 2009 | clinicaltrials |
| NCT00904852 | Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme | withdrawn | Phase 1 | 30 | Millennium Pharmaceuticals, Inc.INDUSTRY | 0 | May 20, 2009 | clinicaltrials |
| NCT00185861 | Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma | completed | Phase 1 | 12 | Stanford UniversityOTHER | 1 | Apr 9, 2009 | clinicaltrials |
| NCT00080054 | A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas | completed | Phase 1 | 24 | Pharmacyclics LLC.INDUSTRY | 1 | Apr 3, 2009 | clinicaltrials |
| NCT00114309 | 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma | unknown | Phase 2 | 66 | TransMolecularINDUSTRY | 1 | Apr 3, 2009 | clinicaltrials |
| NCT00152126 | Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas | completed | N/A | 26 | St. Jude Children's Research HospitalOTHER | 1 | Feb 13, 2009 | clinicaltrials |
| NCT00115440 | BNCT to Treat Glioma That Has Progressed Following Radiotherapy | completed | Phase 1 / Phase 2 | 22 | Boneca CorporationINDUSTRY | 1 | Jan 28, 2009 | clinicaltrials |
| NCT00365222 | Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma | terminated | Phase 2 | 1 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 22, 2009 | clinicaltrials |
| NCT00083447 | Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme | withdrawn | Phase 3 | 323 | Xenova BiomedixINDUSTRY | 2 | Jan 7, 2009 | clinicaltrials |
| NCT00157703 | G207 Followed by Radiation Therapy in Malignant Glioma | completed | Phase 1 | 9 | MediGeneINDUSTRY | 1 | Dec 16, 2008 | clinicaltrials |
| NCT00306618 | Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma | completed | Phase 2 | 27 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Dec 10, 2008 | clinicaltrials |
| NCT00481455 | Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM) | completed | Phase 2 | 15 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00336531 | Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation | completed | Phase 4 | 100 | Samsung Medical CenterOTHER | 1 | Nov 19, 2008 | clinicaltrials |
| NCT00115453 | Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma | terminated | Phase 1 / Phase 2 | 50 | Boneca CorporationINDUSTRY | 1 | Aug 18, 2008 | clinicaltrials |
| NCT00717210 | Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide(NOA-04) | completed | Phase 3 | 318 | Neuro-Oncology Working Group of the German Cancer SocietyNETWORK | 1 | Jul 17, 2008 | clinicaltrials |
| NCT00582049 | Research on the Environment and Children's Health: Retinoblastoma | completed | — | 78 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 4, 2008 | clinicaltrials |
| NCT00553748 | Phase I, Open Label, Single Center Safety Study of [F-18]FLT | completed | Phase 1 | 11 | Siemens Molecular ImagingINDUSTRY | 1 | Jul 3, 2008 | clinicaltrials |
| NCT00135135 | Therapy for Children With Neuroblastoma | completed | Phase 2 | 23 | St. Jude Children's Research HospitalOTHER | 1 | Jun 3, 2008 | clinicaltrials |
| NCT00186862 | Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma | completed | Phase 1 | 24 | St. Jude Children's Research HospitalOTHER | 1 | Jun 3, 2008 | clinicaltrials |
| NCT00460876 | Phase I Trial of Periocular Topotecan in Retinoblastoma | completed | Phase 1 | 5 | Hospital JP GarrahanOTHER_GOV | 1 | May 2, 2008 | clinicaltrials |
| NCT00187109 | Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy | completed | Phase 1 / Phase 2 | 40 | St. Jude Children's Research HospitalOTHER | 1 | Apr 10, 2008 | clinicaltrials |
| NCT00068952 | Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme | completed | Phase 3 | 118 | PfizerINDUSTRY | 13 | Apr 1, 2008 | clinicaltrials |
| NCT00001148 | Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor | completed | — | 25 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001171 | Evaluation of Factors in Human Brain Tumors | completed | — | 800 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001335 | New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma | completed | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001502 | A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001509 | A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001565 | Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00250887 | Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research | completed | Phase 2 | 22 | University of ZurichOTHER | 1 | Oct 23, 2007 | clinicaltrials |
| NCT00180791 | High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood | unknown | Phase 2 | 71 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 18, 2007 | clinicaltrials |
| NCT00521482 | Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma | unknown | Phase 2 | 40 | University of ZurichOTHER | 1 | Aug 28, 2007 | clinicaltrials |
| NCT00505141 | Urban Environmental Exposures and Childhood Cancer | completed | — | — | Georgetown UniversityOTHER | 1 | Jul 23, 2007 | clinicaltrials |
| NCT00394628 | AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme | unknown | Phase 1 / Phase 2 | 60 | NovaceaINDUSTRY | 1 | May 30, 2007 | clinicaltrials |
| NCT00455286 | a Phase II Study in Primary Central Nervous System Lymphoma | unknown | Phase 2 | 25 | National Health Research Institutes, TaiwanOTHER | 1 | Apr 4, 2007 | clinicaltrials |
| NCT00430911 | Radiotherapy for Malignant Astrocytomas in the Elderly | completed | Phase 3 | — | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 2, 2007 | clinicaltrials |
| NCT00190723 | A Study of LY317615 in Patients With Brain Tumors | completed | Phase 2 | 120 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00074646 | Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas | completed | Phase 1 | 36 | Celgene CorporationINDUSTRY | 1 | Jan 4, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Nov 9, 2009source: clinicaltrials